- Home
- CIK vs XGN Comparison
CIK vs XGN Comparison
Compare CIK & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CIK | XGN |
|---|---|---|
| Founded | N/A | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 127.8M | 110.7M |
| IPO Year | 1995 | 2014 |
Fundamental Metrics
Financial Performance| Metric | CIK | XGN |
|---|---|---|
| Price | $2.34 | $7.51 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $10.57 |
| AVG Volume (30 Days) | ★ 419.3K | 325.4K |
| Earning Date | 01-01-0001 | 11-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $11.02 |
| Revenue Next Year | N/A | $10.28 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.26 | $2.59 |
| 52 Week High | $2.88 | $10.41 |
Technical Indicators
Market Signals| Indicator | CIK | XGN |
|---|---|---|
| Relative Strength Index (RSI) | 62.48 | 56.91 |
| Support Level | $2.26 | $7.81 |
| Resistance Level | $2.40 | $8.94 |
| Average True Range (ATR) | 0.03 | 0.53 |
| MACD | 0.01 | 0.06 |
| Stochastic Oscillator | 91.67 | 79.78 |
Price Performance
Historical ComparisonAbout CIK Credit Suisse Asset Management Income Fund Inc.
Credit Suisse Asset Mgmt Income Fund Inc is a closed-end management investment company. The investment objective of the fund is to provide current income consistent with the preservation of capital. UBS Asset Management serves as an investment adviser for the fund. Asset Management offers a wide range of investment products and functions across asset classes and investment styles. The division manages various regional portfolios, mutual funds, and other investment vehicles for governments, institutions, corporations and individuals.
About XGN Exagen Inc.
Exagen Inc is a medical technology company focused on the design, development and commercialization of diagnostic testing products under its AVISE brand. These products are used for the differential diagnosis, prognosis, and monitoring of rheumatic, autoimmune, and related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). The company operates in one operating segment. The majority of the company's revenue is derived from sales of its testing products.